Page 245 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 245
P0720 IMPROVEMENT OF ADVANCED LIVER FIBROSIS AND ePOSTERS
REGRESSION OF LIVER CIRRHOSIS IN PATIENTS WITH
P0721 HEPATITIS C GENOTYPE 1 AFTER HCV PROTEASE
P0722 INHIBITOR-BASED TRIPLE THERAPY
P0723 Federico Sáez-Royuela, Pedro Linares, Luis A. Cervera,
P0724 Carolina Almohalla, Francisco Jorquera, Isidro García, Adriana Moncada,
P0725 Guillermo Karpman, Ester Badia*, María A. A. Vallecillo, Sara Lorenzo,
José L. Olcoz, Spain
VIRAL AND HOST PARAMETERS IN ASSOCIATION WITH
OUTCOME OF ACUTE HEPATITIS C IN HIV-COINFECTED
PATIENTS
Julia Dietz*, Thomas Lutz, Gaby Knecht, Peter Gute, Caterina Berkowski,
Christian M. Lange, Pavel Khaykin, Christoph Stephan, Hans-
Reinhard Brodt, Stefan Zeuzem, Christoph Sarrazin, Germany
NON-INVASIVE DETECTION, STRATIFICATION AND
TREATMENT OF CHRONIC HEPATIC C RELATED
LIVER DISEASE AMONGST SUBSTANCE USERS IN THE
COMMUNITY: A PROSPECTIVE STUDY
Margaret O’Sullivan*, Hugh Williams, Anna-Marie Jones, Sumita Verma,
The United Kingdom
HCV REINFECTION INCIDENCE DECLINE AMONG HIV-
POSITIVE MEN WHO HAVE SEX WITH MEN IN THE UK
Thomas C. Martin*, Natasha Martin, Alison Tang, Mark Nelson,
The United Kingdom
DIRECT MEDICAL COSTS ASSOCIATED WITH THE
EXTRAHEPATIC MANIFESTATIONS OF HEPATITIS C
INFECTION IN THE UNITED STATES
Zobair Younossi*, Maria Stepanova, Linda Henry, Haesuk Park,
Andrei Racila, Zahra Younoszai, Sharon Hunt, The United States
LIPIDOMICS ANALYSIS OF FASTING SERUM IDENTIFIES
NOVEL LIPID BIOMARKERS SPECIFIC FOR HCV
GENOTYPE 3 AND GENOTYPE 1 CHRONIC HEPATITIS C
VIRUS INFECTION
David A. Sheridan*, Maria Gomez Romero, Simon Bridge, Mary Crossey,
Isaac T. Shawa, Dermot Neely, Daniel Felmlee, Elaine Holmes,
Maggie Bassendine, Simon Taylor-Robinson, The United Kingdom
Vienna, Austria • April 22–26, 2015 245
REGRESSION OF LIVER CIRRHOSIS IN PATIENTS WITH
P0721 HEPATITIS C GENOTYPE 1 AFTER HCV PROTEASE
P0722 INHIBITOR-BASED TRIPLE THERAPY
P0723 Federico Sáez-Royuela, Pedro Linares, Luis A. Cervera,
P0724 Carolina Almohalla, Francisco Jorquera, Isidro García, Adriana Moncada,
P0725 Guillermo Karpman, Ester Badia*, María A. A. Vallecillo, Sara Lorenzo,
José L. Olcoz, Spain
VIRAL AND HOST PARAMETERS IN ASSOCIATION WITH
OUTCOME OF ACUTE HEPATITIS C IN HIV-COINFECTED
PATIENTS
Julia Dietz*, Thomas Lutz, Gaby Knecht, Peter Gute, Caterina Berkowski,
Christian M. Lange, Pavel Khaykin, Christoph Stephan, Hans-
Reinhard Brodt, Stefan Zeuzem, Christoph Sarrazin, Germany
NON-INVASIVE DETECTION, STRATIFICATION AND
TREATMENT OF CHRONIC HEPATIC C RELATED
LIVER DISEASE AMONGST SUBSTANCE USERS IN THE
COMMUNITY: A PROSPECTIVE STUDY
Margaret O’Sullivan*, Hugh Williams, Anna-Marie Jones, Sumita Verma,
The United Kingdom
HCV REINFECTION INCIDENCE DECLINE AMONG HIV-
POSITIVE MEN WHO HAVE SEX WITH MEN IN THE UK
Thomas C. Martin*, Natasha Martin, Alison Tang, Mark Nelson,
The United Kingdom
DIRECT MEDICAL COSTS ASSOCIATED WITH THE
EXTRAHEPATIC MANIFESTATIONS OF HEPATITIS C
INFECTION IN THE UNITED STATES
Zobair Younossi*, Maria Stepanova, Linda Henry, Haesuk Park,
Andrei Racila, Zahra Younoszai, Sharon Hunt, The United States
LIPIDOMICS ANALYSIS OF FASTING SERUM IDENTIFIES
NOVEL LIPID BIOMARKERS SPECIFIC FOR HCV
GENOTYPE 3 AND GENOTYPE 1 CHRONIC HEPATITIS C
VIRUS INFECTION
David A. Sheridan*, Maria Gomez Romero, Simon Bridge, Mary Crossey,
Isaac T. Shawa, Dermot Neely, Daniel Felmlee, Elaine Holmes,
Maggie Bassendine, Simon Taylor-Robinson, The United Kingdom
Vienna, Austria • April 22–26, 2015 245
